lobbying_activities: 1309842

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1309842	191bb4bf-1427-49ae-bdd1-83dc4e075044	Q3	BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC	292972	BOEHRINGER INGELHEIM USA CORPORATION	2012	third_quarter	PHA	Drug Shortages; The Preserving Access to Life Saving Medicines Act (S. 296)	Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE		710000	0	0	2012-10-19T11:07:16.370000-04:00